Toos Daemen

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Topics

Psychometric Properties

Oxidative Stress

Hepatitis C Virus

Top Venues

Cancer immunology, immunotherapy : CII

Redox report : communications in free radical research

PLoS computational biology

This page only lists publications with an associated author ORCID identifier.

Publications

Shipeng Chen, Yuzhen Gao, Ying Wang, Toos Daemen
The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus-related hepatocellular carcinoma. International journal of cancer 151 (5) (2022)
Darshak Kartikey Bhatt, Thijs Janzen, Toos Daemen, Franz J Weissing
Modelling the spatial dynamics of oncolytic virotherapy in the presence of virus-resistant tumour cells. PLoS computational biology 18 (12) (2022)
Cesar Oyarce, Ana Vizcaino-Castro, Shipeng Chen, Annemarie Boerma, Toos Daemen
Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs. Oncoimmunology 10 (1) (2021)
W Alfredo Ríos-Ocampo, Toos Daemen, Manon Buist-Homan, Klaas Nico Faber, Maria-Cristina Navas, Han Moshage
Hepatitis C virus core or NS3/4A protein expression preconditions hepatocytes against oxidative stress and endoplasmic reticulum stress. Redox report : communications in free radical research 24 (1) (2020)
Stephanie van de Wall, Karl Ljungberg, Peng Peng Ip, Annemarie Boerma, Maria L Knudsen, Hans W Nijman, Peter Liljeström, Toos Daemen
Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens. Oncoimmunology 7 (10) (2018)
Amrita Singh, Georgia Koutsoumpli, Stephanie van de Wall, Toos Daemen
An alphavirus-based therapeutic cancer vaccine: from design to clinical trial. Cancer immunology, immunotherapy : CII 68 (5) (2018)
Fenne L Komdeur, Thalina M Prins, Stephanie van de Wall, Annechien Plat, G Bea A Wisman, Harry Hollema, Toos Daemen, David N Church, Marco de Bruyn, Hans W Nijman
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer. Oncoimmunology 6 (9) (2017)